These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19956954)

  • 1. Progress in understanding inflammatory and autoimmune diseases of the central nervous system.
    Hohlfeld R; Kappos L
    Semin Immunopathol; 2009 Nov; 31(4):437-8. PubMed ID: 19956954
    [No Abstract]   [Full Text] [Related]  

  • 2. [The central nervous system and inflammation: the role of opioid peptides].
    Mazzone A; Ricevuti G; Fioravanti A; Pasotti D; Vitto AR; Mirto L; Vignali C; Avato F; Notario A
    Medicina (Firenze); 1990; 10(1):23-5. PubMed ID: 1974317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The increasing importance of inflammation in neurological disease.
    Bone I
    Curr Opin Neurol; 2007 Jun; 20(3):331-3. PubMed ID: 17495629
    [No Abstract]   [Full Text] [Related]  

  • 4. Demyelination in peroxisomal diseases.
    Powers JM
    J Neurol Sci; 2005 Feb; 228(2):206-7. PubMed ID: 15694208
    [No Abstract]   [Full Text] [Related]  

  • 5. Autoimmune disease and the nervous system.
    Steinman L
    West J Med; 1992 Jun; 156(6):664-6. PubMed ID: 1615671
    [No Abstract]   [Full Text] [Related]  

  • 6. Immune and inflammatory mechanisms in neuropathic pain.
    Moalem G; Tracey DJ
    Brain Res Rev; 2006 Aug; 51(2):240-64. PubMed ID: 16388853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune encephalomyelitis and the connection between the nervous and immune systems.
    Abramsky O; Weidenfeld J; Ovadia H
    Isr J Med Sci; 1990 Dec; 26(12):686-8. PubMed ID: 2272794
    [No Abstract]   [Full Text] [Related]  

  • 8. Vasoactive intestinal peptide regulates Th17 function in autoimmune inflammation.
    Leceta J; Gomariz RP; Martinez C; Carrión M; Arranz A; Juarranz Y
    Neuroimmunomodulation; 2007; 14(3-4):134-8. PubMed ID: 18073504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-immune interactions and disease susceptibility.
    Marques-Deak A; Cizza G; Sternberg E
    Mol Psychiatry; 2005 Mar; 10(3):239-50. PubMed ID: 15685252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptors as targets for inflammation, development and repair in the central nervous system.
    van Noort JM
    Curr Opin Investig Drugs; 2007 Jan; 8(1):60-5. PubMed ID: 17263186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astrocytes as targets for neuroprotective drugs.
    Darlington CL
    Curr Opin Investig Drugs; 2005 Jul; 6(7):700-3. PubMed ID: 16044665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of intravenous immunoglobulin therapy in autoimmune and inflammatory disorders.
    Emmi L; Chiarini F
    Neurol Sci; 2002 Apr; 23 Suppl 1():S1-8. PubMed ID: 12032582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The immune status of Schwann cells: what is the role of the P2X7 receptor?].
    Colomar A; Marty V; Combe C; Médina C; Parnet P; Amédée T
    J Soc Biol; 2003; 197(2):113-22. PubMed ID: 12910626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTOR--beyond transplantation.
    Young DA; Nickerson-Nutter CL
    Curr Opin Pharmacol; 2005 Aug; 5(4):418-23. PubMed ID: 15955739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglial involvement in experimental autoimmune inflammation of the central and peripheral nervous system.
    Gehrmann J; Gold R; Linington C; Lannes-Vieira J; Wekerle H; Kreutzberg GW
    Glia; 1993 Jan; 7(1):50-9. PubMed ID: 8380791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis: immunopathologic mechanisms in the progression and resolution of inflammatory demyelination.
    Raine CS
    Res Publ Assoc Res Nerv Ment Dis; 1990; 68():37-54. PubMed ID: 1691521
    [No Abstract]   [Full Text] [Related]  

  • 17. In situ demonstration of proliferating cells in the rat central nervous system during experimental autoimmune encephalomyelitis. Evidence suggesting that most infiltrating T cells do not proliferate in the target organ.
    Ohmori K; Hong Y; Fujiwara M; Matsumoto Y
    Lab Invest; 1992 Jan; 66(1):54-62. PubMed ID: 1731149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD40/CD40L dyad in the inflammatory and immune responses in the central nervous system.
    Chen K; Huang J; Gong W; Zhang L; Yu P; Wang JM
    Cell Mol Immunol; 2006 Jun; 3(3):163-9. PubMed ID: 16893496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurogenic aspects of inflammation.
    Schaible HG; Del Rosso A; Matucci-Cerinic M
    Rheum Dis Clin North Am; 2005 Feb; 31(1):77-101, ix. PubMed ID: 15639057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter to the Editor Re: "an inflammatory review of glucocorticoids in the CNS" by Sorrells et al. Brain, Behavior and Immunity 21, 259-272, 2007.
    Miller AH
    Brain Behav Immun; 2007 Oct; 21(7):988-9; author reply 990. PubMed ID: 17643955
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.